Bill tracker, H.Res. 1285, Health

Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.

  1. Introduced
  2. In committee
  3. Reported
  4. Agreed to in the House

Introduced May 14, 2026 with 54 cosponsors. Latest action May 14, 2026: Referred to the House Committee on Energy and Commerce.

Sponsor

Committees

Timeline

CommitteeHouseSenatePresidentJunMay 14, 2026: Submitted in HouseMay 14, 2026: Referred to the House Committee on Energy and Commerce.
PassedFailed, tabled or vetoedBecame lawOther steps

What happened to it

Related bills

Full history

    • ReferredHouse. Referred to the House Committee on Energy and Commerce.
    • IntroducedSubmitted in House

Read the bill on Congress.gov